Seattle Children’s licenses gene-editing therapy to Casebia Therapeutics and will partner on further research – GeekWire
GeekWire |
Seattle Children's licenses gene-editing therapy to Casebia Therapeutics and will partner on further research
GeekWire The tech is based on work by Dr. David Rawlings, who leads Seattle Children's Center for Immunity and Immunotherapies, and Dr. Andrew Scharenberg, who co-led the Program in Cell and Gene Therapy before joining Casebia as its chief scientific officer. |
